Skip to content
10-Q

Quarterly Report

Adverum Biotechnologies, Inc.

0001628280-25-039761

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 20.98M sh
Shares Diluted Q2 2025 · Jun 30, 2025 21.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 20.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 20.85M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.71M sh
Capex Q2 2025 · Jun 30, 2025 $340K
Capex Q2 2025 · Jun 30, 2024 $106K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$81.54M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$43.09M
Short Term Investments Q2 2025 · Jun 30, 2025 $1.98M
Short Term Investments Q2 2025 · Dec 31, 2024 $65.04M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $42.42M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $60.65M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $127.32M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$20.22M
Stockholders Equity Q2 2025 · Mar 31, 2025 $26.42M
Stockholders Equity Q2 2025 · Dec 31, 2024 $70.71M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $137.4M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $163.68M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 $67.22M
Current Liabilities Q2 2025 · Jun 30, 2025 $31.36M
Current Liabilities Q2 2025 · Dec 31, 2024 $22.9M
Total Liabilities Q2 2025 · Jun 30, 2025 $116.4M
Total Liabilities Q2 2025 · Dec 31, 2024 $109.13M
Current Assets Q2 2025 · Jun 30, 2025 $48.39M
Current Assets Q2 2025 · Dec 31, 2024 $131.3M
Total Assets Q2 2025 · Jun 30, 2025 $96.18M
Total Assets Q2 2025 · Dec 31, 2024 $179.84M
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.59
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$1.46
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.08
Eps Basic Q2 2025 · Jun 30, 2025 −$2.34
Eps Basic Q2 2025 · Jun 30, 2025 −$4.59
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1.46
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.08
Sga Expense Q2 2025 · Jun 30, 2025 $12.73M
Sga Expense Q2 2025 · Jun 30, 2025 $32.2M
Sga Expense restated Q2 2025 · Jun 30, 2024 $15.81M
Sga Expense restated Q2 2025 · Jun 30, 2024 $29.6M
Rd Expense Q2 2025 · Jun 30, 2025 $37.13M
Rd Expense Q2 2025 · Jun 30, 2025 $65.87M
Rd Expense Q2 2025 · Jun 30, 2024 $17.1M
Rd Expense Q2 2025 · Jun 30, 2024 $32.51M
Net Income Q2 2025 · Jun 30, 2025 −$49.19M
Net Income Q2 2025 · Jun 30, 2025 −$96.21M
Net Income Q2 2025 · Mar 31, 2025 −$47.02M
Net Income restated Q2 2025 · Jun 30, 2024 −$30.5M
Net Income restated Q2 2025 · Jun 30, 2024 −$57.65M
Net Income restated Q2 2025 · Mar 31, 2024 −$27.15M
Operating Income Q2 2025 · Jun 30, 2025 −$49.86M
Operating Income Q2 2025 · Jun 30, 2025 −$98.08M
Operating Income restated Q2 2025 · Jun 30, 2024 −$32.9M
Operating Income restated Q2 2025 · Jun 30, 2024 −$62.1M